Virtual Reality Experience for Analgesia Management for External Cephalic Version

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Analgesia Management for External Cephalic Version
Virtual Reality Experience - Other
Eligibility
18 - 65
Female
What conditions do you have?
Select

Study Summary

This trial will compare VR to no VR during ECV to see if VR is more effective at reducing pain.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Analgesia Management for External Cephalic Version

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: Within 5 minutes of the end of the ECV procedure

The maximal rated pain score will be determined within 5 minutes of the end of the ECV procedure.
Mean maximal numerical rating scale (NRS) score ( scale 0 - 10) for pain during the ECV procedure.
Hour 2
Rating of the likelihood of choosing the analgesia technique received again
Within 5 minutes of the end of the ECV procedure
Success of ECV procedure

Trial Safety

Safety Progress

1 of 3

Other trials for Analgesia Management for External Cephalic Version

Trial Design

2 Treatment Groups

Group No VR
1 of 2
Group VR
1 of 2
Active Control
Experimental Treatment

52 Total Participants · 2 Treatment Groups

Primary Treatment: Virtual Reality Experience · No Placebo Group · N/A

Group VR
Other
Experimental Group · 1 Intervention: Virtual Reality Experience · Intervention Types: Other
Group No VRNoIntervention Group · 1 Intervention: Group No VR · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: within 5 minutes of the end of the ecv procedure

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,282 Previous Clinical Trials
1,613,030 Total Patients Enrolled
Allison Lee, MDPrincipal InvestigatorColumbia University
3 Previous Clinical Trials
207 Total Patients Enrolled

Eligibility Criteria

Age 18 - 65 · Female Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 18th, 2021

Last Reviewed: October 25th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.